Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein

Jang Ho J. Cha, Laurie A. Farrell, Sharlin F. Ahmed, Ariel Frey, Karen K. Hsiao-Ashe, Anne B. Young, John B. Penney, Joseph J. Locascio, Bradley T. Hyman, Michael C. Irizarry

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Alzheimer's disease transgenic mice overexpressing human amyloid precursor protein (hAPP) with the Swedish double mutation (hAPPSw) develop age-related amyloid deposition and behavioral and electrophysiologic changes by an unknown mechanism. Analysis of glutamatergic receptor subtypes in 4- and 15-month-old heterozygous hAPPSw transgenic mice revealed a selective increase in AMPA receptor binding in the hippocampus of 15-month-old transgenic mice, which have established cortical and hippocampal amyloid deposits. There were no significant alterations of GluR1, GluR2, and GluR4 protein expression by semiquantitative confocal analysis or GluR1 mRNA by in situ hybridization. There was no significant alteration in NMDA, in group I and II metabotropic glutamate and in muscarinic receptor binding, or in striatal dopamine and adenosine receptor binding in 15-month-old mice. These data suggest that mutant APP overexpression or age-related amyloid deposition produce a subtle specific alteration in hippocampal glutamate receptors with aging.

Original languageEnglish (US)
Pages (from-to)90-102
Number of pages13
JournalNeurobiology of Disease
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint Dive into the research topics of 'Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein'. Together they form a unique fingerprint.

Cite this